Morning, Tuesday, 30th June 2020
THIS EVENT IS CPD CERTIFIED
This conference will assess the progress and next steps in rolling out social prescribing across England and the next steps for scaling up - looking at:
- development of the workforce and integration into the care network;
- increasing and evaluating the evidence base; and
- next steps and priorities going forward.
It follows the announcement that the Government has set up the National Academy for Social Prescribing (NASP) backed by 5m in funding, with the aim of increasing provision of social prescribing in England.
Delegates will discuss how the Academy should approach its goals in:
- improving and standardising the quality and range of social prescriptions available to patients across the country;
- championing the benefits of social prescribing by building and promoting the evidence base;
- developing and sharing best practice, as well as look at new models and sources of funding;
- bringing together all partners from health, housing and local government with arts, culture and sporting organisations to maximise the role of social prescribing; and
- the development of training and accreditations across sectors.
Speakers and chair
There will be keynote contributions from:
- Dr Michael Dixon, National Clinical Lead, Social Prescribing, NHS England; Co-Chair, Social Prescribing Network and Chairman, College of Medicine; and
- James Sanderson, Chief Executive, National Academy for Social Prescription and Director, Personalised Care, NHS England and NHS Improvement.
Further confirmed speakers include: Professor Sheena Asthana, University of Plymouth; Dr Bogdan Chiva Giurca, Harvard Global Health Institute; Stephen Critchlow, Evergreen Life; Dan Lyus, South West Academic Health Science Network and Alyson Mcgregor, Altogether Better and Catherine Wills, Northamptonshire CCGs.
Baroness Pitkeathley, President, National Council for Voluntary Organisations has agreed to chair a session at this seminar.
- Assessing the progress of rolling out social prescribing in England;
- Developing the social prescribing workforce - integration, training and accreditation;
- Commissioning of social prescription and implementation of personalised care;
- Assessing effectiveness and quality - evaluation of outcomes and next steps for developing the evidence base;
- Promotion, patient engagement and delivery of social prescription; and
- Long term goals for establishing best practice, scaling up and the sourcing and allocation of funding